Health

Inaugural Health and Wellbeing Forum Discussed about Co-creating Healthier Hong Kong for all

This event brought together over 60 representatives from patient organizations, academia, and healthcare community to explore the possibilities of achieving maximum health equity inHong Kong HONG KONG, Oct. 9, 2024 /PRNewswire/ -- Pfizer Hong Kong held its inaugural "Health & Well-being Forum" t...

2024-10-09 22:17 1895

SERVING MORE THAN LOOKS: MAYBELLINE NEW YORK ANNOUNCES NAOMI OSAKA AS THE BRAND'S FIRST BRAVE TOGETHER AMBASSADOR

The four-time Grand Slam tennis champion and mental health advocate teams up with Maybelline New York for World Mental Health Day to amplify the Brave Together program   NEW YORK, Oct. 9, 2024 /PRNewswire/ -- In honor of World Mental Health Day on October 10, Maybelline New York is maximizing it...

2024-10-09 21:00 2265

Public Interest Registry Unveils Winners of 6th Annual .ORG Impact Awards at DC Ceremony Hosted by Emmy Winner Alan Cumming

Yellow Boat of Hope Foundation named 2024 .ORG of the Year, selected from over 1,700 applicants from more than 87 countries WASHINGTON, Oct. 9, 2024 /PRNewswire/ -- Public Interest Registry (PIR), the people behind the .ORG domain, announced the winners of the.ORG Impact Awards, an annual celebr...

2024-10-09 21:00 2505

ZEISS expands ophthalmic offerings to improve patient care with new digital AI tools and revolutionary surgical solutions

  Showcasing at AAO 2024: * ZEISS VisioGen offers a cutting-edge, AI-driven solution designed to enhance refractive patient communication and streamline clinic operations. * ZEISS Milestone: Celebrating more than 10 million eyes treated with lenticule extraction solutions utilizing ZEISS SMIL...

2024-10-09 21:00 1884

ShiraTronics Raises $66 Million in Oversubscribed Series B Financing to Advance Pioneering Treatment for Chronic Migraine

Implantable Neuromodulation System Shows Early Promise in Improving Patient Quality of Life by Reducing Monthly Headache Days and Severity of Migraine Attacks MINNEAPOLIS, Oct. 9, 2024 /PRNewswire/ -- ShiraTronics, a clinical-stage medical device company developing neurostimulation therapies fo...

2024-10-09 20:12 1197

International Collaboration Addresses Rising Cancer Rates in South America

National Comprehensive Cancer Network and Latin American Cooperative Oncology Group to publish cancer treatment guidelines tailored forBrazil. PLYMOUTH MEETING, Pa., Oct. 9, 2024 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the Unite...

2024-10-09 20:07 1120

New INTREPID Alliance Antiviral Landscape Report Highlights Urgent Need to Bolster R&D Pipeline in Support of Global Pandemic Preparedness Efforts

Current mpox outbreak underscores gaps in access to medical countermeasures to help mitigate the severity of future outbreaks CAMBRIDGE, Mass., Oct. 9, 2024 /PRNewswire/ -- Today, the INTREPID Alliance, a consortium of innovative biopharmaceutical companies dedicated to accelerating antiviral tr...

2024-10-09 19:00 1108

Spring Growth Spurt, Witsbb Vitamin D for Babies Popular at Leading Australian Pharmacy Chains

SYDNEY, Oct. 9, 2024 /PRNewswire/ -- Should newborn babies supplement with vitamin D? How should vitamin D be supplemented? As global consumers' health awareness significantly increases, the demand for nutritional supplements is showing trends towards refinement, diversification, and personalizat...

2024-10-09 16:50 1442

The CDE has Granted Breakthrough Therapy Designation to LBL-024, a Bispecific Antibody that Targets PD-L1 and 4-1BB, Developed by Leads Biolabs, for the Treatment of Extrapulmonary Neuroendocrine Carcinoma.

NANJING, China, Oct. 9, 2024 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs") announced that Center for Drug Evaluation (CDE) of National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation to LBL-024, an anti-PD-L1/4-1BB bispecific antibody indepe...

2024-10-09 13:38 1533

AWAK Transforms into Vivance, Unveiling a New Brand Identity

SINGAPORE, Oct. 9, 2024 /PRNewswire/ -- AWAK Technologies, a pioneer in innovative kidney care is excited to announce its rebranding toVivance. The name, derived from 'viva' and 'advance', embodies vitality and progress - hallmarks of the company's commitment to revolutionizing kidney health. AW...

2024-10-09 08:00 1604

High tech specs and adapted World Cup pitch sensors awarded share of £1.5m as finalists in Longitude Prize on Dementia

* AI glasses that help people living with dementia navigate their environment and a smartwatch that learns daily routines to assist in everyday tasks are among five groundbreaking technologies announced as finalists in The Longitude Prize on Dementia * The Longitude Prize on Dementia is a £4....

2024-10-09 02:30 1910

Seegene and Werfen Finalize Partnership Agreement on Technology-Sharing Initiative

* Werfen, a worldwide leader in specialized diagnostics, becomes the first European company to finalize the partnership agreement to join Seegene's technology-sharing initiative * The two companies will co-establish a NewCo in Spain to serve as a strategic hub inEurope, accelerating global ex...

2024-10-08 21:00 1620

LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance

GAITHERSBURG, Md., Oct. 8, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for in...

2024-10-08 20:30 3083

Pierre Fabre Laboratories and Scorpion Therapeutics Announce First Patient Dosed in Phase I/II Clinical Trial of PFL-241/STX-241, a Mutant-Selective Inhibitor Intended To Treat Locally Advanced or Metastatic Non-Small Cell Lung Cancer

PFL-241/STX-241 is a highly selective, and potentially best-in-class fourth generation epidermal growth factor receptor ("EGFR") inhibitor One of two EGFR programs being developed with Scorpion Therapeutics CASTRES, France and BOSTON, Oct. 8, 2024 /PRNewswire/ -- Pierre Fabre Laboratories, a glo...

2024-10-08 20:00 1330

Healgen Scientific Receives FDA De Novo Marketing Authorization for At-Home COVID-19 and Influenza Test

Healgen Rapid Check® COVID-19/Flu A&B Antigen Test was supported through the Independent Test Assessment Program (ITAP), a National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech program. HOUSTON, Oct. 8, 2024 /PRNewswire/ -- Healgen Scientific LLC, a leading innovator...

2024-10-08 19:00 1221

Pop culture meets a sense of wellbeing: inspiring ToyTrends for Spielwarenmesse 2025

* Two new trends: 'Anime & Friends' and 'Healthy Heroes' * Perfect position: new central location at Eingang Mitte NUREMBERG, Germany, Oct. 8, 2024 /PRNewswire/ -- From 28 January to 1 February 2025, Nuremberg will again become the centre of the global toy sector. The international TrendCommi...

2024-10-08 16:07 1176

Herbalife Sets GUINNESS WORLD RECORDS™ Title with 2024 Worldwide Workout

More than 4,900 fitness enthusiasts from around the world participated in a high-intensity interval training workout LOS ANGELES, Oct. 8, 2024 /PRNewswire/ -- Herbalife , a premier health and wellness company, community and platform, has made history by setting a...

2024-10-08 11:00 4333

Registrational Phase III Studies of APG-2449 Cleared by China CDE for the Treatment of Patients with NSCLC

ROCKVILLE, Md. and SUZHOU, China, Oct. 8, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that APG-2449, a FAK/ALK...

2024-10-08 10:26 1469

Han's Robot to Showcase its Innovative Collaborative Robots at Industrial Transformation ASIA-PACIFIC (ITAP) in Singapore

SHENZHEN, China, Oct. 8, 2024 /PRNewswire/ -- From October 14-16, Han's Robot, a leading player in collaborative robotics, will participate in Industrial TransformationASIA-PACIFIC (ITAP) 2024 at the Singapore EXPO. ITAP is the premier event in theAsia-Pacific region for businesses adopting and s...

2024-10-08 10:00 4069

Empowering Elder Care: DKSH's Mission for "Patient Purpose Day 2024"

For the second consecutive year, DKSH Healthcare Business Unit is marking "Patient Purpose Day 2024" with a series of impactful initiatives acrossAsia dedicated to elder care. These programs, which include health screenings, educational workshops, and donation drives, aim to meet the needs of ...

2024-10-08 09:00 3325
1 ... 12131415161718 ... 580